Drug Trial Radar · NCT07758634
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
69
Planned (sponsor's estimate)
Start
Sep 25, 2026
Primary completion
Jul 1, 2028
Study completion Jul 1, 2029
Sponsor
- Lead sponsor
- CRISPR Therapeutics AGIndustry
- Sponsor type
- Industry
- First posted
- Aug 11, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Study of CTX340 in Participants with Uncontrolled Hypertension.
Conditions
- Hypertension
Interventions
CTX340Drug
CTX340 is an in vivo gene editing therapy designed to utilize clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9 (CRISPR-Cas9) to target and disrupt human angiotensinogen (AGT) gene in liver.
PlaceboDrug
One of the arms in Phase 2 will be placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1: Incidence of dose-limiting toxicities (DLTs)Time frame: Up to 12 months
- Phase 2: Percentage change in circulating angiotensinogen (AGT) concentration from baselineTime frame: Through 6 months of follow-up.
Locations
11 sites in 3 countries. Site status is shown where the registry gives one.
Flourish Research - Jacksonville
Jacksonville, Florida · Recruiting
Flourish Research - Orlando
Orlando, Florida · Recruiting
United Medical Research (Progressive Research)
Port Orange, Florida · Recruiting
University of Rochester
Rochester, New York · Recruiting
Duke
Durham, North Carolina · Recruiting
Peters Medical Research
High Point, North Carolina · Recruiting
Oregon Health & Science University (OHSU)
Portland, Oregon · Recruiting
Monash Medical Center
Melbourne, Australia · Recruiting
Richmond Pharmacology
London, United Kingdom · Recruiting
University Hospitals Birmingham
Birmingham, England, United Kingdom · Recruiting
Royal Papworth Hospital
Cambridge, England, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.